May 26, 2023 05:34 AM EDTUpdated 01:31 PM

Stephen Hahn’s cancer-testing biotech hires a new CMO; Former Iovance exec named CEO of Obsidian

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Andrew Dunn

Senior Biopharma Correspondent

Flagship Pioneering’s blood cancer testing startup Harbinger Health has brought in drug industry veteran May Orfali as its new chief medical …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Stephen Hahn’s cancer-testing biotech hires a new CMO; Former Iovance exec named CEO of Obsidian

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Andrew Dunn

Senior Biopharma Correspondent

Sign up to read this article for free.

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Pfizer CEO says opportunities with Trump ‘clearly outweigh’ the risks for pharma

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Stephen Hahn’s can­cer-test­ing biotech hires a new CMO; For­mer Io­vance ex­ec named CEO of Ob­sid­i­an

Copy Chief

Editor

Senior Biopharma Correspondent

Sign up to read this article for free.

Stephen Hahn’s cancer-testing biotech hires a new CMO; Former Iovance exec named CEO of Obsidian